HELLP syndrome on the rise: a major cause of maternal deaths
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20221433Keywords:
HELLP syndrome, HDP, Maternal mortality, PRAKI, Blood products, Immediate deliveryAbstract
Background: In the recent years, 2021 to 2022, there has been a sudden rise in the number of HELLP syndrome cases admitted to Modern Government Maternity Hospital, (MGMH) / Osmania Medical College. There were maternal deaths due to complications secondary to HELLP syndrome. Complications like placental abruption, DIC, PPH, PRAKI, pulmonary edema, were responsible for maternal deaths. The need for blood products has increased enormously. In our earlier study of eclampsia and imminent eclampsia from the same Institute, during 2004 to 2007, we did not find HELLP syndrome to be a major cause of maternal deaths. Hence, we proceeded with in depth study of the complications, morbidity and mortality and some management issues related to HELLP syndrome. All 70 cases of HELLP in this study had associated Preeclampsia/eclampsia.
Methods: This is a prospective analytical observational study of 70 cases of HELLP syndrome.
Results: Recurrent preeclampsia was noted in 6÷45=13.33%. Cases of hypothyroidism were observed in 6÷45=13.33%. There were four sets of twins, 8.88%. Placental abruption was noted in 10/70 women with HELLP, 14.28%, DIC occurred in 15÷70=21.42%, PPH occurred in 11÷45 cases, 24.44%, PRAKI was recorded in 16/70 patients, 22.85%, Pulmonary edema occurred in 5/70, 7.14%, PPCM in cases with HELLP syndrome were 2÷70=2.85%, Abdominal delivery was needed in 53÷70=75.71%, Maternal mortality in the present study was10÷70=14.28%, The perinatal mortality was 21.33%. Blood products were needed in 22/45 cases, (9.136) units on the average.
Conclusions: Dissemination of knowledge that immediate delivery should be planned in all cases of HELLP, irrespective of gestational age is the need of the hour. Postponing delivery would lead to complications.
Metrics
References
Marchand A, Galen RS, Van LF. The predictive value of serum haptoglobin in hemolytic disease. JAMA. 1980;243:1909-11.
Wilke G, Rath W, Schutz E, Armstrong VW, Kuhn W. Haptoglobin as a sensitive marker of hemolysis in HELLP-syndrome. Int J Gynaecol Obstet. 1992;39:29-34.
Gammill HS, Chettier R, Brewer A. Cardiomyopathy and preeclampsia. Circulation. 2018;138:2359-66.
Curtin WM, Weinstein L. A review of HELLP syndrome. J Perinatol. 1999;19:138-43.
Sibai BM, Taslimi MW, El-Nazer A, Amon E, Mabie BG, Regan GM. Maternal- perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol. 1986;155(3):501-8.
Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol. 1990;162:311-6.
Lokki AI, Haapio M, Heikkinen-Eloranta J. Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS—Case Report. Front. Immunol. 2020;11:548.
Kaur AP, Kaur N, Dhillon SPS. HELLP syndrome and its implications on maternal and perinatal outcome. Int J Reprod Contracept Obstet Gynecol. 2018;7(3):1007-11.
Magann EF, Martin JN Jr. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol. 1999;42:532-50.
Ağaçayak E, Bugday R, Peker N, Deger U, Kavak GO, Evsen MS et al. Factors Affecting ICU Stay and Length of Stay in the ICU in Patients with HELLP Syndrome in a Tertiary Referral Hospital. Int J Hypertens. 2022.
Osmanagaoglu MA, Osmanagaoglu S, Ulusoy H, Bozkaya H. Maternal outcome in HELLP syndrome requiring intensive care. Am J Obstet Gynecol. 2000;36(183):444-8.
Devabhaktuni P, Konkathi AK. Placental abruption an obstetric emergency: management and outcomes in 180 cases. Int J Reprod Contracept Obstet Gynecol 2020;9:212-4.
Devabhaktuni P, Nagasree MGS. Abruptio placentae 116 cases: role of PGE1 in cervical ripening and induction of labor. Open J Obstet Gynecol. 2008;8:585-97.
Bahadur BR, Kodey PD, Mula A. Maternal and fetal outcome in HELLP syndrome. International Journal of Clinical Obstetrics and Gynaecology. 2019;3(4):140-4.
Devabhaktuni P, Chennapragada S, Manchala S, Menon R, Patil N, Bhupatiraju S. Peripartum cardiomyopathy management-multidisciplinary approach 2011-2013 at Care Institute of Medical Sciences. 2011-2013 at CIMS. Int J Reprod Contracept Obstet Gynecol. 2020;9:4883-91.
Rakshit A, Lahiri S, Biswas SC, Dey R, Roy BR, Saha MM. A study to detect HELLP syndrome and partial HELLP syndrome among preeclamptic mothers and their impact on fetomaternal outcome. Al Ameen J Med Sci. 2014;7(1):20-5.
Devabhaktuni P, Addula MR, Ponnur M, Kasu B, Ramakoti S, Reddy H. Management of eclampsia and imminent eclampsia, maternal and perinatal outcome in 666 cases-2003-2007 at Government Maternity Hospital in Hyderabad. Open J Obstet and Gynecol. 2017;7(2):193-207.
Devabhaktuni P, Samavedam S, Thota GVS, Pusala SV, Velaga K, Bommakanti L et al, Clinical profile and outcome of obstetric ICU patients. APACHE II, SOFA, SAPS II and MPM scoring systems for prediction of prognosis. Open Journal of Obstetrics and Gynecology. 2013;3:41-50.
Devabhaktuni P, Ponnuru M, Devang CL, Rao PV. Glycosylated fibronectin positivity in the spectrum of hypertensive disorders of pregnancy in relation to the severity and adverse outcomes. Int J Reprod Contracept Obstet Gynecol. 2022;11.
Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: Clinical issues and management. A Review. BMC Pregnancy and Childbirth. 2009;9:8.
Rimaitis K, Grauslyte L, Zavackiene A, Baliuliene V, Nadisauskiene R, Macas A, Diagnosis of HELLP Syndrome: A 10-Year Survey in a Perinatology Centre. Int J Environ Res Public Health. 2019;16:109.
Martin JN, Rinehart B, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: Comparative analysis by HELLP syndrome classification. Am J Obstet Gynecol. 1999;180:1373-84.
Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004;31:807-33.
Downloads
Published
How to Cite
Issue
Section
